PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Prostatic Neoplasms D011471 126 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Edema D004487 152 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Yu Y et al. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. 2002 Biochim. Biophys. Acta pmid:12020636
Cao J et al. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium. 2002 Eur. J. Pharmacol. pmid:12020689
Sawano H et al. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells. 2002 Kidney Int. pmid:12028436
Kondo M et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12032289
Krishnaswamy G et al. Regulation of eosinophil-active cytokine production from human cord blood-derived mast cells. 2002 J. Interferon Cytokine Res. pmid:12034046
Lennon AM et al. MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. 2002 J. Biol. Chem. pmid:12052825
Fujino T et al. Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells. 2002 Br. J. Pharmacol. pmid:12055131
Ward C et al. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. 2002 J. Immunol. pmid:12055237
Zander T et al. Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. 2002 J. Neurochem. pmid:12065618
Yagami T et al. Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis. 2002 J. Neurochem. pmid:12065654
Wang YL et al. Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival. 2002 J. Biol. Chem. pmid:12082115
Huang WC et al. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. 2002 Exp. Cell Res. pmid:12083801
Wayman NS et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. 2002 FASEB J. pmid:12087064
Lee B et al. Prostaglandin D synthase in the prenatal ovine brain and effects of its inhibition with selenium chloride on fetal sleep/wake activity in utero. 2002 J. Neurosci. pmid:12097519
Fernández-Tomé Mdel C et al. Phospholipase C inhibitors and prostaglandins differentially regulate phosphatidylcholine synthesis in rat renal papilla. Evidence of compartmental regulation of CTP:phosphocholine cytidylyltransferase and CDP-choline:1,2-diacylglycerol cholinephosphotransferase. 2002 Biochim. Biophys. Acta pmid:12117562
Menè P Prostaglandin D2 : a Cinderella of vascular cell biology? 2002 J. Hypertens. pmid:12131515
Negoro H et al. Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells. 2002 J. Hypertens. pmid:12131531
Nencioni A et al. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. 2002 J. Immunol. pmid:12133943
Kudoh I et al. [Prostanoids and acute lung injury]. 2002 Masui pmid:12134647
Yamamoto S et al. Agents that elevate cyclic AMP induce receptor phosphorylation primarily at serine 331 in HEK 293 cells overexpressing human thromboxane receptor alpha. 2002 Biochem. Pharmacol. pmid:12147288
Sakurai S et al. Retinal capillary pericyte proliferation and c-Fos mRNA induction by prostaglandin D2 through the cAMP response element. 2002 Invest. Ophthalmol. Vis. Sci. pmid:12147615
Saito S et al. Prostaglandin D2 and reproduction. 2002 Am. J. Reprod. Immunol. pmid:12148545
Miyazaki Y et al. Inhibitory effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of IgE heavy chain germline transcripts in the human B cell line DND39. 2002 Biochem. Biophys. Res. Commun. pmid:12150985
Meier CA et al. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma. 2002 Cytokine pmid:12160520
Chen SY et al. 15-Deoxy-delta12,14-prostaglandin J2 induces apoptosis of a thyroid papillary cancer cell line (CG3 cells) through increasing intracellular iron and oxidative stress. 2002 Anticancer Drugs pmid:12187333
Kohyama T et al. PGD(2) modulates fibroblast-mediated native collagen gel contraction. 2002 Am. J. Respir. Cell Mol. Biol. pmid:12204901
Gebhardt T et al. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release. 2002 Eur. J. Immunol. pmid:12209644
Cox B et al. Human colorectal cancer cells efficiently conjugate the cyclopentenone prostaglandin, prostaglandin J(2), to glutathione. 2002 Biochim. Biophys. Acta pmid:12213491
Marx N PPARgamma and vascular inflammation: adding another piece to the puzzle. 2002 Circ. Res. pmid:12215484
Takata Y et al. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma. 2002 Circ. Res. pmid:12215492
Ahn SG et al. Sox-4 is a positive regulator of Hep3B and HepG2 cells' apoptosis induced by prostaglandin (PG)A(2) and delta(12)-PGJ(2). 2002 Exp. Mol. Med. pmid:12216117
Nencioni A et al. Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. 2002 Exp. Hematol. pmid:12225793
Hunt MJ and Tyagi SC Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation. 2002 Am. J. Physiol., Cell Physiol. pmid:12225971
Mössner R et al. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma. 2002 J. Invest. Dermatol. pmid:12230498
Iwasaki M et al. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. 2002 J. Invest. Dermatol. pmid:12230502
Jozkowicz A et al. Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1. 2002 Antioxid. Redox Signal. pmid:12230869
Haslmayer P et al. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. 2002 Int. J. Oncol. pmid:12239635
Chen GG et al. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer. 2002 Life Sci. pmid:12269390
Skolnik PR et al. Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects. 2002 J. Acquir. Immune Defic. Syndr. pmid:12352144
Eligini S et al. 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. 2002 Thromb. Haemost. pmid:12353085
Suzuki K and Uyeda M Inhibitory properties of antitumor prostaglandins against topoisomerases. 2002 Biosci. Biotechnol. Biochem. pmid:12353631
Campo PA et al. Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2). 2002 Cell Growth Differ. pmid:12354750
Lappas M et al. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. 2002 J. Clin. Endocrinol. Metab. pmid:12364456
Vitzthum H et al. Gene expression of prostanoid forming enzymes along the rat nephron. 2002 Kidney Int. pmid:12371957
Higashi N et al. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. 2002 Clin. Exp. Allergy pmid:12372129
Zhang J et al. 15-Deoxy-prostaglandin J(2) inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPAR gamma. 2002 Biochem. Biophys. Res. Commun. pmid:12379230
Hu VY et al. COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat. 2003 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:12388444
Piliponsky AM et al. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. 2003 Blood pmid:12393403
Suzuki-Nishimura T and Uchida MK Prostaglandin D2 generation by rat peritoneal mast cells stimulated with Datura stramonium agglutinin and its inhibition by haptenic sugar and wheat germ agglutinin. 2002 Jpn. J. Pharmacol. pmid:12396030
Clay CE et al. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. 2002 J. Lipid Res. pmid:12401880
Imaizumi T et al. 15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells. 2002 Immunol. Cell Biol. pmid:12406386
Kim SY et al. Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses. 2002 Phytother Res pmid:12410540
Jawerbaum A et al. Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy Delta12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis. 2002 Reproduction pmid:12417000
Kubata BK et al. A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. 2002 J. Exp. Med. pmid:12417633
Shahbazian A et al. Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine. 2002 Br. J. Pharmacol. pmid:12429577
Fahmi H et al. 15d-PGJ(2) is acting as a 'dual agent' on the regulation of COX-2 expression in human osteoarthritic chondrocytes. 2002 Osteoarthr. Cartil. pmid:12435328
Yang X et al. Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells. 2002 Am. J. Respir. Cell Mol. Biol. pmid:12444028
Nikitakis NG et al. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells. 2002 Br. J. Cancer pmid:12454768
Badawi AF and Badr MZ Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis. 2003 Int. J. Cancer pmid:12455057
Gueck T et al. Influence of vitamin E on mast cell mediator release. 2002 Vet. Dermatol. pmid:12464062
Kalla R et al. Loss of microglial ramification in microglia-astrocyte cocultures: involvement of adenylate cyclase, calcium, phosphatase, and Gi-protein systems. 2003 Glia pmid:12465045
Sawyer N et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. 2002 Br. J. Pharmacol. pmid:12466225
Satoh T and Watanabe Y [Cyclopentenone prostaglandin derivatives as neuroprotective compounds]. 2002 Tanpakushitsu Kakusan Koso pmid:12486935
Larsen P et al. Calcium-stimulated short-circuit currents in the canine proximal colonic epithelium: effects of DK-PGD2, a metabolite of prostaglandin D2. 2002 Can. J. Physiol. Pharmacol. pmid:12489928
Monneret G et al. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils. 2003 J. Pharmacol. Exp. Ther. pmid:12490611
Satoh T [Neurotrophin-like low molecular weight compounds]. 2002 Nippon Yakurigaku Zasshi pmid:12491808
Li L et al. RasGRP4 regulates the expression of prostaglandin D2 in human and rat mast cell lines. 2003 J. Biol. Chem. pmid:12493770
Winnett G et al. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. 2003 Int. J. Cancer pmid:12494466
Nithipatikom K et al. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. 2002 Clin. Exp. Metastasis pmid:12498388
Arici M et al. Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. 2003 J. Am. Soc. Nephrol. pmid:12506134
Weber SM et al. Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2. 2003 Am. J. Physiol. Endocrinol. Metab. pmid:12517740
Pang L et al. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. 2003 J. Immunol. pmid:12517972
Neuschäfer-Rube F et al. Identification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptor. 2003 Biochem. J. pmid:12519077
Calnek DS et al. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12524224
Li LH and Ku BS [Regulation of SWS by hormones and cytokines]. 2000 Sheng Li Ke Xue Jin Zhan pmid:12532764
Farrow B and Evers BM Activation of PPARgamma increases PTEN expression in pancreatic cancer cells. 2003 Biochem. Biophys. Res. Commun. pmid:12535639
Desmond JC et al. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. 2003 Cancer Res. pmid:12543809
Castrillo A et al. Potentiation of protein kinase C zeta activity by 15-deoxy-delta(12,14)-prostaglandin J(2) induces an imbalance between mitogen-activated protein kinases and NF-kappa B that promotes apoptosis in macrophages. 2003 Mol. Cell. Biol. pmid:12556480
Moore RM et al. Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. 2003 Feb-Mar Placenta pmid:12566244
Tanaka H et al. Possible involvement of prostaglandins F(2alpha) and D(2) in acetylcholine-induced positive inotropy in isolated mouse left atria. 2003 Pharmacology pmid:12571412
Söderström M et al. Novel prostaglandin D(2)-derived activators of peroxisome proliferator-activated receptor-gamma are formed in macrophage cell cultures. 2003 Biochim. Biophys. Acta pmid:12573447
Gibbons H et al. Hypothermia suppresses inducible nitric oxide synthase and stimulates cyclooxygenase-2 in lipopolysaccharide stimulated BV-2 cells. 2003 Brain Res. Mol. Brain Res. pmid:12573534
Park EJ et al. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. 2003 J. Biol. Chem. pmid:12584205
Patel HJ et al. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. 2003 J. Immunol. pmid:12594295
Ruan XZ et al. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. 2003 J. Am. Soc. Nephrol. pmid:12595494
Cuzzocrea S et al. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. 2003 Br. J. Pharmacol. pmid:12598422
Hinz B et al. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism. 2003 Biochem. Biophys. Res. Commun. pmid:12604364
Jung KM et al. Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2. 2003 Mol. Pharmacol. pmid:12606768
Hirano A et al. Arachidonic acid-induced channel- and carrier-type ion transport across planar bilayer lipid membranes. 2003 Anal Sci pmid:12608744
Abe M et al. GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12615657
Qin C et al. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells. 2003 Cancer Res. pmid:12615709
Kanehara H et al. Thrombomodulin expression by THP-1 but not by vascular endothelial cells is upregulated by pioglitazone. 2002 Thromb. Res. pmid:12617986
Kajekar R et al. Role of cyclooxygenase activation and prostaglandins in antigen-induced excitability changes of bronchial parasympathetic ganglia neurons. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12618420
Wanichkul T et al. Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells. 2003 Fertil. Steril. pmid:12620489
Taba Y et al. 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12623786
Hashimoto K et al. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. 2002 Int J Gastrointest Cancer pmid:12630765
Tzanakakis GN et al. The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis. 2002 Int J Gastrointest Cancer pmid:12630766
Lee CH and Edwards AM Differential expression of c-fos and c-myc protooncogenes by estrogens, xenobiotics and other growth-stimulatory agents in primary rat hepatocytes. 2003 Arch. Toxicol. pmid:12632255
Lee TS et al. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2. 2003 J. Biol. Chem. pmid:12642589
Houston KD et al. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. 2003 Cancer Res. pmid:12649180